Skip to main content
. Author manuscript; available in PMC: 2019 Feb 22.
Published in final edited form as: Cell. 2018 Feb 22;172(5):924–936.e11. doi: 10.1016/j.cell.2018.02.006

Table 1. Summary of molecular and clinical symptoms of 15 individuals with PUM1 mutations.

Mb, megabase; nt, nucleotide; –, not known. *Subject 9’s clinical details were taken from Wilson BT., et al, 2015 (Wilson et al., 2015) and Decipher (Firth et al., 2009). R, Arginine; W, Tryptophan; S, Serine; T, Threonine. Subj., Subjects; AD, autosomal dominant inheritance. See also Table S1 and S3.

PADDAS syndrome PRCA syndrome
Feature Subj. 1 Subj. 2 Subj. 3 Subj. 4 Subj. 5 Subj. 6 Subj. 7 Subj. 8 Subj. 9* Subj. 10 Subj. 11 Subj. 12 Subj. 13 Subj. 14 Subj.15
Gender male male female female female female female female female male
Current age 16 years 2 years 6 months 7 years 9 years 9 years 59 years 58 years 52 years 81 years (deceased)
Age of onset < 5 years 5 months early 30s early 30s early 40s early 50s
Chr1 (hg19): 28751378- 33588455 29600988- 31598923 28716929- 32629424 31442430- 31720099 31284806- 31872758 31239605- 33825029 31113947- 32897001 28743173- 34340430 31091243- 33142346 31409510 31406186 31414862 31414862 31414862 31414862
Size 4.84 Mb 1.9 Mb 3.91 Mb 0.3 Mb 0.6 Mb 2.6 Mb 1.78 Mb 5.6 Mb 2.05 Mb 1 nt 1 nt 1 nt 1 nt 1 nt 1 nt
Nucleotide change deletion deletion deletion deletion deletion deletion deletion deletion deletion G > A G > A T > A T > A T > A T > A
AA change R1139W R1147W T1035S T1035S T1035S T1035S
Type deletion deletion deletion deletion deletion deletion deletion deletion deletion missense missense missense missense missense missense
Inheritance de novo de novo de novo de novo de novo AD AD AD AD
Developmental delay yes yes yes yes yes yes yes yes yes yes yes no no no no
Intellectual disability yes yes yes yes yes yes yes no yes no no no no
Seizures yes no yes yes no yes no no no no
Ataxia yes yes no yes yes yes yes yes yes yes yes yes yes
Progressive yes no yes yes yes yes yes